Literature DB >> 8574209

The best of times, the worst of times. The global challenge of antimicrobial resistance.

F C Tenover1.   

Abstract

The development of resistance to antimicrobial agents by many bacterial pathogens has compromised traditional therapeutic regimens, making treatment of infections more difficult and frequently more expensive. Three factors have contributed to the development and spread of resistance: mutations in common genes that extend their spectrum of resistance, transfer of resistance genes among diverse microorganisms and increases in selective pressures in and outside of the hospital environment that enhance the development of resistant organisms. Some new resistance mechanisms are difficult to detect in the laboratory. Thus, resistant microorganisms may go unnoticed until they are widely disseminated in a hospital. The challenge for pharmacists, microbiologists and physicians is not only to contain the spread of existing resistant organisms, but also to prevent the emergence of new resistant pathogens by encouraging the rational and prudent use of antimicrobial agents.

Mesh:

Substances:

Year:  1995        PMID: 8574209     DOI: 10.1007/bf01879708

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  37 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 2.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  Quinolones. An overview.

Authors:  H C Neu
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Mar-Apr       Impact factor: 2.803

Review 4.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.

Authors:  B E Murray; B Mederski-Samoraj; S K Foster; J L Brunton; P Harford
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 6.  Drug-resistant Salmonella in the United States: an epidemiologic perspective.

Authors:  M L Cohen; R V Tauxe
Journal:  Science       Date:  1986-11-21       Impact factor: 47.728

7.  Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.

Authors:  G P Katsanis; J Spargo; M J Ferraro; L Sutton; G A Jacoby
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes.

Authors:  W Sougakoff; S Goussard; G Gerbaud; P Courvalin
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

9.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

Authors:  B R Edlin; J I Tokars; M H Grieco; J T Crawford; J Williams; E M Sordillo; K R Ong; J O Kilburn; S W Dooley; K G Castro
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

10.  Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood.

Authors:  J T Weber; E D Mintz; R Cañizares; A Semiglia; I Gomez; R Sempértegui; A Dávila; K D Greene; N D Puhr; D N Cameron
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

View more
  3 in total

1.  Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever.

Authors:  John Wain; L T Diem Nga; Claire Kidgell; Keith James; Sarah Fortune; To Song Diep; Tahir Ali; Peadar O Gaora; Christopher Parry; Julian Parkhill; Jeremy Farrar; Nicholas J White; Gordon Dougan
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 2.  Healthy environments for healthy people: bioremediation today and tomorrow.

Authors:  C Bonaventura; F M Johnson
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

3.  Pseudobacteremia outbreak of biofilm-forming Achromobacter xylosoxidans - environmental transmission.

Authors:  Frank Günther; Uta Merle; Uwe Frank; Matthias M Gaida; Nico T Mutters
Journal:  BMC Infect Dis       Date:  2016-10-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.